Heading up the next session to discuss exciting kidneycancer research. GU19pic.twitter.coms8FdvJ7DDZ

Heading up the next session to discuss exciting #kidneycancer research. #GU19pic.twitter.com/s8FdvJ7DDZ

13:05 EST 16 Feb 2019 | Merck & Co., Inc.

Heading up the next session to discuss exciting #kidneycancer research. #GU19 pic.twitter.com/s8FdvJ7DDZ

More From BioPortfolio on "Heading up the next session to discuss exciting #kidneycancer research. #GU19pic.twitter.com/s8FdvJ7DDZ"